Mr. Xin  Wang
My Social Links

Mr. Xin Wang

Research Scholar
University of Houston, USA


Highest Degree
Ph.D. Student in Pharmaceutical Sciences from University of Houston, USA

Share this Profile

Area of Interest:

Pharmacology and Toxicology
100%
Addictive Behaviors
62%
Behavioral Health
90%
Managed Care
75%
Clinical Studies
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Zamil, D., X. Wang, A. Vadhariya and H. Chen, 2017. Demographic trends in ADHD diagnosis in us children using NHANES data between 2004 and 2012. Value Health, 20: A237-A237.
  2. Wu, I.H., H. Chen, P. Bordnick, E.J. Essien and M. Johnson et al., 2017. Comparison of suicide attempts/behaviors following smoking cessation treatments among schizophrenic smokers. Arch. Psychiatric Nursing, 31: 62-67.
    CrossRef  |  Direct Link  |  
  3. Wang, X., H. Chen, E.J. Essien, M. Yang and S. Abughosh, 2017. Predictors of a successful outcome among adult smokers in the United States. J. Behav. Health, 6: 4-15.
  4. Abughosh, S., X. Wang, O. Serna, T. Esse and A. Mann et al., 2017. A motivational interviewing intervention by pharmacy students to improve medication adherence. J. Managed Care Specialty Pharm., 23: 549-560.
    CrossRef  |  Direct Link  |  
  5. Yang, M., H. Chen, M.L. Johnson, E.J. Essien, R.J. Peters, X. Wang and S. Abughosh, 2016. Comparison of abstinence rates of smoking cessation medications among obese smokers. J. Behav. Health, 5: 95-104.
    CrossRef  |  
  6. Yang, M., H. Chen, M.L. Johnson, E.J. Essien, R.J. Peters, X. Wang and S. Abughosh, 2016. Comparative effectiveness of smoking cessation medications to attenuate weight gain following cessation. Substance Use Misuse, 51: 586-597.
    CrossRef  |  Direct Link  |  
  7. Wu, I., H. Chen, P. Bordnick, E.J. Essien and M.L. Johnson et al., 2016. Comparative effectiveness of smoking cessation medications among schizophrenic smokers. Value Health, 19: A119-A120.
    CrossRef  |  Direct Link  |  
  8. Wang, X., I. Wu, H. Chen, P. Bordnick and E.J. Essien et al., 2016. Comparison of cardiovascular risks following smoking cessation treatments using varenicline versus nrt among schizophrenic smokers. Value Health, 19: A182-A183.
  9. Abughosh, S.M., X. Wang, O. Serna, C. Henges and S. Masilamani et al., 2016. A pharmacist telephone intervention to identify adherence barriers and improve adherence among nonadherent patients with comorbid hypertension and diabetes in a medicare advantage plan. J. Managed Care Specialty Pharm., 22: 63-73.
    CrossRef  |  Direct Link  |  
  10. Yang, M., V. Bali, H. Mehta, P. Gupta, X. Wang, R.R. Aparasu and M.L. Johnson, 2015. Which comorbidity index performs better in predicting 30-day mortality?-A systematic review. J. Eval. Clin. Pract., 21: 292-299.
  11. Wang, X., S. Abughosh, R.J. Peters and E.J. Essien, 2015. Racial and ethnic disparity in smoking cessation medication use among adult smokers in the United States. J. Behav. Health, 4: 63-70.
    CrossRef  |  Direct Link  |  
  12. Wang, X. and X.L. Du, 2015. Socio-demographic and geographic variations in the utilization of hormone therapy in older women with breast cancer after medicare part-D coverage. Med. Oncol., Vol. 32. 10.1007/s12032-015-0599-6.
    CrossRef  |  Direct Link  |  
  13. Fleming, M.L., E.A. Ferries, M.D. Hatfield, N. Atreja and A. Yucel et al., 2015. Patients' beliefs regarding counseling provided by community pharmacists: An application of the theory of planned behavior. J. Pharm. Health Serv. Res., 6: 77-79.
    CrossRef  |  Direct Link  |  
  14. Abughosh, S., E.J. Essien, F. Hawari, R.J. Peters and X. Wang et al., 2015. Predictors of cigarette smoking across five countries: A cross-sectional study. J. Behav. Health, 4: 7-13.
    CrossRef  |  
  15. Yang, M., D. Bhowmik, X. Wang and S. Abughosh, 2013. Does combination pharmacological intervention for smoking cessation prevent post-cessation weight gain? A systemic review. Addictive Behav., 38: 1865-1875.
    CrossRef  |  Direct Link  |